MAIA — Maia Biotechnology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Maia Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	10.6	11	7.15	9.6	8.66
Net Total Receivables	—	0.303	0.145	0.077	0
Prepaid Expenses
Total Current Assets	10.7	11.8	7.56	10.2	9.7
Other Long Term Assets
Total Assets	11.3	12	7.57	10.2	9.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.15	3.27	4.94	3.83	5.84
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	2.15	3.51	7.09	6.52	7.33
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	9.18	8.51	0.478	3.63	2.38
Total Liabilities & Shareholders' Equity	11.3	12	7.57	10.2	9.7
Total Common Shares Outstanding